Insider Transactions in Q3 2018 at Entasis Therapeutics Holdings Inc. (ETTX)
Insider Transaction List (Q3 2018)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 28
2018
|
Astrazeneca PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
246,666
+10.23%
|
$3,699,990
$15.0 P/Share
|
Sep 28
2018
|
Astrazeneca PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,918,185
+50.0%
|
-
|
Sep 28
2018
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,089,835
+33.31%
|
$16,347,525
$15.0 P/Share
|
Sep 28
2018
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,092,008
+50.0%
|
-
|